These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16960469)

  • 1. Lamotrigine as an add-on treatment for depersonalization disorder: a retrospective study of 32 cases.
    Sierra M; Baker D; Medford N; Lawrence E; Patel M; Phillips ML; David AS
    Clin Neuropharmacol; 2006; 29(5):253-8. PubMed ID: 16960469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder.
    Sierra M; Phillips ML; Ivin G; Krystal J; David AS
    J Psychopharmacol; 2003 Mar; 17(1):103-5. PubMed ID: 12680746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine in the immediate treatment of outpatients with depersonalization disorder without psychiatric comorbidity: randomized, double-blind, placebo-controlled study.
    Aliyev NA; Aliyev ZN
    J Clin Psychopharmacol; 2011 Feb; 31(1):61-5. PubMed ID: 21192145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depersonalization disorder: pharmacological approaches.
    Sierra M
    Expert Rev Neurother; 2008 Jan; 8(1):19-26. PubMed ID: 18088198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes.
    Barbosa L; Berk M; Vorster M
    J Clin Psychiatry; 2003 Apr; 64(4):403-7. PubMed ID: 12716240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Bruno A; Micò U; Pandolfo G; Mallamace D; Abenavoli E; Di Nardo F; D'Arrigo C; Spina E; Zoccali RA; Muscatello MR
    J Psychopharmacol; 2012 Nov; 26(11):1456-62. PubMed ID: 22351381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of lamotrigine in a resistant case of depersonalization disorder.
    Rosagro-Escámez F; Gutiérrez-Fernández N; Gómez-Merino P; de la Vega I; Carrasco JL
    Actas Esp Psiquiatr; 2011; 39(4):263-6. PubMed ID: 21769750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine in the treatment of depersonalization disorder.
    Sierra M; Phillips ML; Lambert MV; Senior C; David AS; Krystal JH
    J Clin Psychiatry; 2001 Oct; 62(10):826-7. PubMed ID: 11816874
    [No Abstract]   [Full Text] [Related]  

  • 9. An open trial of naltrexone in the treatment of depersonalization disorder.
    Simeon D; Knutelska M
    J Clin Psychopharmacol; 2005 Jun; 25(3):267-70. PubMed ID: 15876908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depersonalization and derealization syndrome: report on a case study and pharmacological management.
    Salgado A; Oliveira L; Sierra-Siegert M; Salgado JV
    Braz J Psychiatry; 2012 Dec; 34(4):505-8. PubMed ID: 23429825
    [No Abstract]   [Full Text] [Related]  

  • 11. Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study.
    Normann C; Hummel B; Schärer LO; Hörn M; Grunze H; Walden J
    J Clin Psychiatry; 2002 Apr; 63(4):337-44. PubMed ID: 12000208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder.
    Pinto OC; Akiskal HS
    J Affect Disord; 1998 Dec; 51(3):333-43. PubMed ID: 10333987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
    J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lamotrigine in the treatment of resistant depersonalization disorder: A case report].
    Bout A; Berhili N; Benbrahim M; Aalouane R; Rammouz I
    Encephale; 2018 Feb; 44(1):85-87. PubMed ID: 28602528
    [No Abstract]   [Full Text] [Related]  

  • 15. Lamotrigine use in patients with binge eating and purging, significant affect dysregulation, and poor impulse control.
    Trunko ME; Schwartz TA; Marzola E; Klein AS; Kaye WH
    Int J Eat Disord; 2014 Apr; 47(3):329-34. PubMed ID: 24343841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
    Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
    Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
    Brown EB; McElroy SL; Keck PE; Deldar A; Adams DH; Tohen M; Williamson DJ
    J Clin Psychiatry; 2006 Jul; 67(7):1025-33. PubMed ID: 16889444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.
    McElroy SL; Zarate CA; Cookson J; Suppes T; Huffman RF; Greene P; Ascher J
    J Clin Psychiatry; 2004 Feb; 65(2):204-10. PubMed ID: 15003074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
    J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.
    Kemp DE; Gao K; Fein EB; Chan PK; Conroy C; Obral S; Ganocy SJ; Calabrese JR
    Bipolar Disord; 2012 Nov; 14(7):780-9. PubMed ID: 23107222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.